Multiplex Plymerase Chain Reaction; Massively Parallel Sequencing
CF Mutation Screen; Cystic Fibrosis Mutation Screen; CFTR Screen; CF Carrier Screen; CF Screen; Cystic Fibrosis Carrier Screen
Whole Blood
Quest Diagnostics San Juan Capistrano
LAB01192
Daily
7 Days
3-4 mL Whole Blood
Lavender (EDTA)
Whole blood collected in an EDTA (royal blue-top), ACD Solution A/B (yellow-top) tube, sodium heparin (green-top), lithium heparin (green-top) is also acceptable. 2 mL Saliva in Oragene DNA self-collection kit is also acceptable. Indicate ethnicity of the patients.
Refrigerate-OK/Ambient-OK
Room Temp: 8 Days (14 Days for Saliva); Refrigerated: 8 Days (14 Days for Saliva); Frozen: Unacceptable
4 mL Whole Blood or 2 mL Saliva
3 mL Whole Blood or 2 mL Saliva
General screen for carrier status & assessment of CF risk. This test will identify approx. 90% of Cystic Fibrosis mutations in the Caucasian population, and 97% in the Ashkenazi Jewish population.
Insurance authorization is required prior to draw for outpatients. Ok to send on inpatients. No special send out forms needed.
81220
06-22-21